Results

RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/20583921http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/20583921http://www.w3.org/2000/01/rdf-schema#comment"

Background

T cell differentiation determines susceptibility and resistance to experimental cutaneous leishmaniasis, yet mixed T1/Th2 responses characterize the clinical spectrum of human infection with Leishmania (Viannia) species.

Materials and methods

To discern the interrelationship of T cell differentiation and outcome of human infection, we examined factors that regulate T cell differentiation and Th1/Th2 cytokine responses in asymptomatic infection, active and historical chronic and recurrent cutaneous leishmaniasis. T-bet, GATA-3, Foxp3, and cytokine gene expression were quantified by real-time polymerase chain reaction and correlated with interleukin 2, interferon gamma, tumor necrosis factor alpha, interleukin 4, interleukin 13, and interleukin 10 secretion during in vitro response to live Leishmania panamensis.

Results

Higher GATA-3 expression than T-bet expression occurred throughout the 15 days of coculture with promastigotes; however, neither transcription nor secretion of interleukin 4 was detected. A sustained inverse correlation between GATA-3 expression and secretion of proinflammatory cytokines interferon gamma and tumor necrosis factor alpha was observed in asymptomatic infection. In contrast, higher T-bet expression and a higher ratio of T-bet to GATA-3 characterized active recurrent disease. Down-regulation of T-bet and GATA-3 expression and increased interleukin 2 secretion, compared with control subjects, was directly correlated with Foxp3 expression and interleukin 13 secretion in chronic disease.

Conclusions

Regulation of the inflammatory response rather than biased Th1/Th2 response distinguished asymptomatic and recalcitrant outcomes of infection with Leishmnania viannia species."xsd:string
http://purl.uniprot.org/citations/20583921http://purl.org/dc/terms/identifier"doi:10.1086/653829"xsd:string
http://purl.uniprot.org/citations/20583921http://purl.uniprot.org/core/author"Rojas R."xsd:string
http://purl.uniprot.org/citations/20583921http://purl.uniprot.org/core/author"Saravia N.G."xsd:string
http://purl.uniprot.org/citations/20583921http://purl.uniprot.org/core/author"Diaz Y.R."xsd:string
http://purl.uniprot.org/citations/20583921http://purl.uniprot.org/core/author"Valderrama L."xsd:string
http://purl.uniprot.org/citations/20583921http://purl.uniprot.org/core/date"2010"xsd:gYear
http://purl.uniprot.org/citations/20583921http://purl.uniprot.org/core/name"J Infect Dis"xsd:string
http://purl.uniprot.org/citations/20583921http://purl.uniprot.org/core/pages"406-415"xsd:string
http://purl.uniprot.org/citations/20583921http://purl.uniprot.org/core/title"T-bet, GATA-3, and Foxp3 expression and Th1/Th2 cytokine production in the clinical outcome of human infection with Leishmania (Viannia) species."xsd:string
http://purl.uniprot.org/citations/20583921http://purl.uniprot.org/core/volume"202"xsd:string
http://purl.uniprot.org/citations/20583921http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/20583921
http://purl.uniprot.org/citations/20583921http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/20583921
http://purl.uniprot.org/uniprot/Q9BZS1#attribution-77020F1FA0ED5B2E33EF81D272F15CEFhttp://purl.uniprot.org/core/sourcehttp://purl.uniprot.org/citations/20583921
http://purl.uniprot.org/uniprot/P23771#attribution-77020F1FA0ED5B2E33EF81D272F15CEFhttp://purl.uniprot.org/core/sourcehttp://purl.uniprot.org/citations/20583921
http://purl.uniprot.org/uniprot/Q9UL17#attribution-77020F1FA0ED5B2E33EF81D272F15CEFhttp://purl.uniprot.org/core/sourcehttp://purl.uniprot.org/citations/20583921